HARVARD BIOSCIENCE INC — Director's Dealing 2017

Nov 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2017-10-30

Reporting Person: Eade Katherine A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-01	Common Stock	A	2300	$0.00	Acquired	2300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-30	Non-Qualified Stock Option (right to buy)	$3.33	A	87600	Acquired	2027-10-30	Common Stock, par value $0.01 per share (87600)	Direct

Footnotes

F1: Represents a deferred stock award of 2,300 restricted stock units which vests on December 31, 2017. This retainer award was granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for her service on the board and a committee of the Issuer's Board of Directors. the number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of August, rounded to the nearest 100 shares.

F2: Includes a deferred stock award of 2,300 restricted stock units which vests on December 31, 2017.

F3: The options vest in three equal installments on October 30, 2018, 2019 and 2020.